SFDA says studying 4 COVID-19 vaccines

26/02/2021 Argaam

Logo of SFDA 


The Saudi Food & Drug Authority (SFDA) is studying and evaluating four COVID-19 vaccines, which will be announced when approved, spokesperson Tayseer Al-Mafraj said during a press conference.

 

Vaccine files are received by SFDA, and clinical trials are conducted ahead of direct communication with the possible manufacturers of the vaccines to facilitate all obstacles and arrange application measures. SFDA held several meetings with experts and scientists to study the available data.

 

Final reports are conducted, and notes – if any - are sent to vaccine manufacturers after studying the efficacy and safety of the vaccines, inspecting factories and analyzing the drug errors of the new molecule.

 

On Feb. 18, the drug regulator authorized the use of the British AstraZeneca's COVID-19 vaccine, developed in cooperation with the University of Oxford, Argaam reported.

 

It also approved the registration of Pfizer-BioNTech COVID-19 vaccine in December 2020

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.